Business Context and Reporting Period
This Form 8-K is filed by Better Choice Company Inc. (not SRx Health Solutions, Inc., which is the counterparty to a proposed transaction) for the reporting date of February 19, 2025. The filing addresses a special meeting of stockholders convened to vote on an arrangement transaction with SRx Health Solutions, Inc.
Key Financial Metrics
This filing is a current report regarding corporate governance and a proposed transaction. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data for Better Choice Company Inc. or SRx Health Solutions, Inc. Investors are directed to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, for historical financial data.
Material Changes and Events
- Adjournment of Special Meeting: The special meeting held on February 19, 2025, was immediately adjourned without conducting business to March 21, 2025.
- Reason for Adjournment: The delay allows SRx Health Solutions to pursue its shareholder vote and obtain a final order from the Ontario Superior Court of Justice required to consummate the transaction. It also allows time to update shareholders on corporate actions needed to ensure compliance with NYSE American listing requirements.
- Voting Status: At the time of adjournment, proxies representing approximately 71% of outstanding shares had been submitted, constituting a quorum with sufficient votes to approve all proposals, including the SRx arrangement.
- Record Date: The record date for voting remains January 21, 2025. Stockholders as of this date retain voting rights even if they have subsequently sold their shares.
Guidance, Outlook, and Risks
- Next Steps: The Company intends to file a supplement to the Proxy Statement with the SEC to provide updated materials for stockholder review.
- Meeting Logistics: The rescheduled meeting will be held exclusively via live webcast on March 21, 2025, at 9:00 a.m. Eastern Time.
- Proxy Validity: Previously submitted proxies will be voted at the adjourned meeting unless properly revoked.
- Risks/Contingencies: The transaction is contingent upon SRx obtaining the required court order and shareholder approval, as well as meeting NYSE American listing requirements.
Investor Verification Checklist
- Verify the status of the Ontario Superior Court of Justice order required for the SRx transaction.
- Review the upcoming supplement to the Proxy Statement for updates on NYSE American listing compliance.
- Confirm the final vote count at the March 21, 2025, meeting to ensure the 71% proxy support holds.
- Consult the Form 10-K (filed April 12, 2024) for the most recent audited financial data, as this 8-K contains no financial metrics.